Abstract | BACKGROUND: INVESTIGATIONS: DIAGNOSIS: New-onset diabetes after transplantation associated with a newly described deletion in HNF1B. MANAGEMENT: Minimization of tacrolimus exposure and withdrawal of steroids considerably reduced the patient's insulin requirement, and cholestasis-related pruritus was dramatically improved by administration of ursodeoxycholic acid. Renal ultrasonography and screening for the HNF1B molecular abnormality were offered to the patient's relatives.
|
Authors | Julien Zuber, Christine Bellanné-Chantelot, Claire Carette, Guillaume Canaud, Sandrine Gobrecht, Khaled Gaha, Vincent Mallet, Frank Martinez, Eric Thervet, José Timsit, Christophe Legendre, Danièle Dubois-Laforgue |
Journal | Nature reviews. Nephrology
(Nat Rev Nephrol)
Vol. 5
Issue 8
Pg. 480-4
(Aug 2009)
ISSN: 1759-507X [Electronic] England |
PMID | 19639018
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- HNF1B protein, human
- Immunosuppressive Agents
- Hepatocyte Nuclear Factor 1-beta
|
Topics |
- Adult
- Cholestasis
(immunology)
- Diabetes Mellitus, Type 2
(diagnosis, genetics, immunology)
- Diagnosis, Differential
- Frameshift Mutation
- Hepatocyte Nuclear Factor 1-beta
(genetics)
- Humans
- Immunosuppressive Agents
(therapeutic use)
- Kidney Transplantation
(immunology)
- Male
- Pruritus
(immunology)
|